CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net product revenue	$ 1,496,000	$ 0	$ 1,496,000	$ 0
Cost of products sold	36,000	0	36,000	0
Gross profit	1,460,000	0	1,460,000	0
Operating expenses:
Research and development expenses	4,223,000	4,541,000	8,053,000	11,532,000
Selling, general and administrative expenses	46,778,000	21,804,000	71,246,000	43,439,000
Restructuring expense	0	3,592,000	0	3,592,000
Total operating expense	51,001,000	29,937,000	79,299,000	58,563,000
Operating loss	(49,541,000)	(29,937,000)	(77,839,000)	(58,563,000)
Investment and other income, net	623,000	192,000	816,000	88,000
Interest expense	(2,295,000)	(3,506,000)	(5,554,000)	(5,523,000)
Loss on extinguishment of debt	(13,129,000)	0	(13,129,000)	0
Loss before income taxes	(64,342,000)	(33,251,000)	(95,706,000)	(63,998,000)
Income tax provision (benefit)	90,000	30,193,000	(490,000)	25,870,000
Net loss	$ (64,432,000)	$ (63,444,000)	$ (95,216,000)	$ (89,868,000)
Net loss per share - basic (in dollars per share)	$ (0.83)	$ (1.07)	$ (1.35)	$ (1.52)
Net loss per share - diluted (in dollars per share)	$ (0.83)	$ (1.07)	$ (1.35)	$ (1.52)
Weighted average number of shares outstanding - basic (in shares)	77,246	59,037	70,603	58,931
Weighted average number of shares outstanding - diluted (in shares)	77,246	59,037	70,603	58,931

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Total costs of sales and operating expenses for the period.